Active Biotech Logo

Active Biotech

ACTI | ST

Overview

Corporate Details

ISIN(s):
SE0001137985 (+2 more)
LEI:
549300OJ44CLMRU8YE43
Country:
Sweden
Address:
Scheelevägen 22, 223 63 Lund
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Active Biotech is a biotechnology company that develops pharmaceutical products for medical areas with significant unmet needs, focusing on cancer and inflammatory diseases where the immune system plays a key role. The company leverages its extensive knowledge and portfolio of compounds to advance a pipeline that includes both small, orally active immunomodulatory molecules and antibody-based immunotherapies. Its key development programs target hematological cancers (tasquinimod), inflammatory eye disorders such as uveitis (laquinimod), and solid tumors (naptumomab), the latter in partnership with NeoTX.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Active Biotech. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 08:30
Interim Report
Swedish 497.6 KB
2025-08-21 08:30
Interim Report
English 492.9 KB
2025-06-17 15:15
Major Shareholding Notification
Swedish 10.7 KB
2025-05-28 18:30
Post-Annual General Meeting Information
Annual General Meeting of Active Biotech AB
English 76.1 KB
2025-05-28 18:30
Post-Annual General Meeting Information
Årsstämma i Active Biotech AB
Swedish 74.1 KB
2025-05-08 08:30
Quarterly Report
Swedish 406.4 KB
2025-05-08 08:30
Quarterly Report
English 400.9 KB
2025-05-05 09:00
Regulatory News Service
Active Biotech rapporterar positiva top line-resultat från LION-studien om okul…
Swedish 104.6 KB
2025-05-05 09:00
Regulatory News Service
Active Biotech reports positive top-line results from the LION study on ocular …
English 104.9 KB
2025-04-28 11:00
Pre-Annual General Meeting Information
NOTICE OF ANNUAL GENERAL MEETING
English 98.7 KB
2025-04-28 11:00
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA
Swedish 99.3 KB
2025-02-13 08:30
Annual Report
Swedish 511.4 KB
2025-02-13 08:30
Annual Report
English 506.2 KB
2025-01-31 08:30
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Active Biotech
English 86.2 KB
2025-01-31 08:30
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Active Biotech
Swedish 86.1 KB

Automate Your Workflow. Get a real-time feed of all Active Biotech filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Active Biotech via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-10 Peter Thelin Other Other 164,638,960 8,231,948.00 SEK
2024-11-15 Hans Kolam Other Other 19,800 990.00 SEK
2022-09-05 Aleksandar Danilovski Other Buy 26,672 26,672.00 SEK
2022-04-22 Helen Tuvesson Andersson Other Buy 2,665 3,102.86 SEK
2022-04-21 Helen Tuvesson Andersson Other Buy 37,335 41,767.60 SEK
2021-06-17 Aleksandar Danilovski Other Buy 40,000 60,000.00 SEK
2021-06-01 Michael Shalmi Other Buy 175,000 259,437.50 SEK
2021-04-27 Helen Tuvesson Andersson Other Buy 10,411 16,657.60 SEK
2021-04-27 Helena Eriksson Other Buy 10,000 14,460.00 SEK
2021-04-27 Helen Tuvesson Andersson Other Buy 1,041 1,665.60 SEK

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN
Adocia Logo
Developing novel drug formulations for metabolic diseases like diabetes and obesity for out-licensing.
France ADOC